John, Linu Mary

Semaglutide lowers body weight in rodents via distributed neural pathways.

Gabery, S., Salinas, C. G., Paulsen, S. J., Ahnfelt-Rønne, J., Alanentalo, T., Baquero, A. F., Buckley, S. T., Farkas, E., Fekete, C., Frederiksen, K. S., et al. (2020) · JCI Insight

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 717

GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand

Yang, L., Chang, C.-C., Sun, Z., Madsen, D., Zhu, H., Padkjær, S. B., Wu, X., Huang, T., Hultman, K., Paulsen, S. J., et al. (2017) · Nature Medicine

GDF15 and Related BiomarkersRegulation of Appetite and Obesity

Cited by 668

Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology

Fibroblast Growth Factor ResearchAdipose Tissue and Metabolism

Cited by 576

Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss

Christoffersen, B. Ø., Sanchez‐Delgado, G., John, L. M., Ryan, D. H., Raun, K., & Ravussin, E. (2022) · Obesity

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 142

Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases

Zakariassen, H. L., John, L. M., & Lutz, T. A. (2020) · Basic & Clinical Pharmacology & Toxicology

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 37

Housing-temperature reveals energy intake counter-balances energy expenditure in normal-weight, but not diet-induced obese, male mice

John, L. M., Petersen, N., Gerstenberg, M. K., Torz, L., Pedersen, K., Christoffersen, B. Ø., & Kuhre, R. E. (2022) · Communications Biology

Regulation of Appetite and ObesityAdipose Tissue and Metabolism

Cited by 31